SCLC has been classified based on differential expression of lineage defining transcription factors ASCL1, NeuroD1, and POU2F3, and we chose one model representative of each of these three subtypes (Supplementary Fig. 1d). This evidence concerns the gene POU2F3 and small cell lung carcinoma.